missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CD19 His-tag, Recombinant Protein
HEK293 cells Recombinant Protein
910.00 NOK - 8450.00 NOK
Specifications
Accession Number | P15391 |
---|---|
For Use With (Application) | Control, ELISA, Immunohistochemistry, Western Blot |
Formulation | protein with 0.02% Tween 80, 5% mannitol, 5% trehalose and no preservative |
Gene ID (Entrez) | 930 |
Name | Human CD19 His-tag |
Product Code | Brand | Quantity | Form | Price | Quantity & Availability | ||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Form | Price | Quantity & Availability | ||||
17154273
|
Invitrogen™
A42607 |
50 μg | Lyophilized |
4030.00 NOK
50µg |
In Stock Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | |||
17144273
|
Invitrogen™
A42606 |
5 μg | Lyophilized |
910.00 NOK
5µg |
Estimated Shipment: 22-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | |||
17134273
|
Invitrogen™
A42605 |
5 x 50 μg | Lyophilized |
This item is currently unavailable or has been discontinued. View the product page for possible alternatives. |
|||||
17124273
|
Invitrogen™
A42604 |
5 x 5 μg | Lyophilized |
This item is currently unavailable or has been discontinued. View the product page for possible alternatives. |
|||||
Description
CD19 is a member of the immunoglobulin superfamily and has two Ig like domains. The CD19 molecule is expressed on 100% of the peripheral B cells as defined by expression of kappa or lambda light chains. CD19 appears to be expressed on myeloid leukemia cells, particularly those of monocytic lineage. Leukemia phenotype studies have demonstrated that the earliest and broadest B cell restricted antigen is the CD19 antigen. The receptor for CD19 is an important functional regulator of normal and malignant B cell proliferation, and is expressed in all B cell precursor leukemias. Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. CD19 is a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. Besides being a signal-amplifying coreceptor for the B cell receptor (BCR), CD19 can also signal independently of BCR co-ligation and is a central regulatory component upon which multiple signaling pathways converge. Mutation of the CD19 gene results in hypogammaglobulinemia, whereas CD19 overexpression causes B cell hyperactivity.Specifications
P15391 | |
protein with 0.02% Tween 80, 5% mannitol, 5% trehalose and no preservative | |
Human CD19 His-tag | |
-20°C | |
<1 EU/μg | |
Cd19 | |
Unconjugated | |
Lyophilized |
Control, ELISA, Immunohistochemistry, Western Blot | |
930 | |
HEK293 cells | |
RUO | |
AW495831; B4; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Cd19; CD19 antigen; CD19 molecule; CVID3; differentiation antigen CD19; Leu-12; T-cell surface antigen Leu-12 | |
Human | |
Recombinant | |
≥ 90% |